Total Payments
$3,354
2024 Payments
$809.30
Companies
35
Transactions
249
Medicare Patients
2,850
Medicare Billing
$252,741
Payment Breakdown by Category
Food & Beverage$3,354 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,354 | 249 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $639.71 | 66 | $0 (2024) |
| Novo Nordisk Inc | $352.04 | 27 | $0 (2024) |
| Amgen Inc. | $320.98 | 23 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $255.82 | 16 | $0 (2024) |
| Lilly USA, LLC | $249.36 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $218.91 | 11 | $0 (2024) |
| GlaxoSmithKline, LLC. | $185.62 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $147.02 | 9 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $135.65 | 15 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $98.27 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $809.30 | 51 | ABBVIE INC. ($138.48) |
| 2023 | $793.93 | 53 | ABBVIE INC. ($128.71) |
| 2022 | $1,324 | 111 | ABBVIE INC. ($223.51) |
| 2021 | $425.86 | 34 | AbbVie Inc. ($149.01) |
All Payment Transactions
249 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Gastroenterology | ||||||
| 11/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/14/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $13.54 | General |
| 10/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Inflammation | ||||||
| 09/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.02 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: RESPIRATORY | ||||||
| 09/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.18 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/15/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: RESPIRATORY | ||||||
| 08/06/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Inflammation | ||||||
| 07/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.78 | General |
| 06/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 981 | 3,125 | $262,685 | $97,846 |
| 2022 | 12 | 580 | 1,892 | $181,235 | $58,374 |
| 2021 | 11 | 595 | 1,926 | $184,344 | $57,143 |
| 2020 | 14 | 694 | 792 | $163,497 | $39,378 |
Total Patients
2,850
Total Services
7,735
Medicare Billing
$252,741
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 19 | 1,800 | $50,400 | $32,972 | 65.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 266 | 413 | $107,793 | $25,078 | 23.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 56 | 56 | $37,072 | $15,769 | 42.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 63 | 63 | $16,506 | $6,565 | 39.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 83 | $14,774 | $4,048 | 27.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 266 | 433 | $6,928 | $3,637 | 52.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 37 | $12,950 | $3,463 | 26.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 37 | 37 | $6,179 | $2,794 | 45.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 56 | 56 | $1,400 | $1,372 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 51 | 51 | $1,275 | $1,250 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 53 | $2,968 | $408.81 | 13.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 18 | 18 | $2,790 | $308.16 | 11.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 25 | 25 | $1,650 | $181.29 | 11.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 245 | 391 | $102,184 | $23,358 | 22.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 12 | 1,140 | $31,920 | $19,581 | 61.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 110 | $19,580 | $5,282 | 27.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 17 | 17 | $11,254 | $4,725 | 42.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 38 | 38 | $6,346 | $2,670 | 42.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 46 | 49 | $1,225 | $1,204 | 98.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 26 | 26 | $650.00 | $642.00 | 98.8% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 25 | 25 | $3,955 | $424.42 | 10.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 34 | $1,904 | $248.59 | 13.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 17 | 17 | $1,122 | $117.50 | 10.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 29 | 30 | $480.00 | $88.20 | 18.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 14 | 15 | $615.00 | $33.38 | 5.4% |
About Moshe Kincade, APRN
Moshe Kincade, APRN is a Family healthcare provider based in Topeka, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/15/2017. The National Provider Identifier (NPI) number assigned to this provider is 1407397086.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Moshe Kincade, APRN has received a total of $3,354 in payments from pharmaceutical and medical device companies, with $809.30 received in 2024. These payments were reported across 249 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,354).
As a Medicare-enrolled provider, Kincade has provided services to 2,850 Medicare beneficiaries, totaling 7,735 services with total Medicare billing of $252,741. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Topeka, KS
- Active Since 03/15/2017
- Last Updated 03/15/2017
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1407397086
Products in Payments
- VRAYLAR (Drug) $327.57
- TRINTELLIX (Drug) $205.77
- UBRELVY (Drug) $201.92
- TRELEGY ELLIPTA (Drug) $185.62
- NURTEC ODT (Drug) $163.33
- Otezla (Drug) $149.80
- EVENITY (Biological) $114.92
- MOUNJARO (Drug) $111.20
- JARDIANCE (Drug) $109.68
- Ozempic (Drug) $100.73
- QULIPTA (Drug) $87.16
- BREZTRI (Drug) $82.38
- Rybelsus (Drug) $75.36
- Saxenda (Drug) $74.95
- BELSOMRA (Drug) $69.16
- TRULICITY (Drug) $68.37
- XIFAXAN (Drug) $67.46
- Vascepa (Drug) $61.83
- Adlarity (Drug) $61.73
- FREESTYLE LIBRE 2 (Device) $53.76
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Topeka
Tatum Toland, Aprn, APRN
Family — Payments: $88,932
Family $88,932
Jason Crenshaw, Arnp, Fnp, ARNP, FNP
Family — Payments: $4,875
Family $4,875
Edelis Ocasio, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $4,461
Family $4,461
Diane Wilkins, A.r.n.p, A.R.N.P
Family — Payments: $3,255
Family $3,255
Shannel Millard
Family — Payments: $2,550
Family $2,550
Mariah Kalma, Msn, Aprn, Fnp-C, MSN, APRN, FNP-C
Family — Payments: $2,543
Family $2,543